+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
ID07704840

Evaluating Oral BMS-986368 for Treating Spasticity After Stroke A Randomized, Double-Blind, Placebo-Controlled Phase 2 Pilot Trial

Led by Alberto Esquenazi · Updated on 2026-10-01

42

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the drug BMS-986368 for treating post-stroke spasticity in adults who have had a stroke. Post-stroke spasticity affects muscles causing tightness and spasms, impairing upper-limb function and daily activities. Current treatments often provide limited relief and have side effects, so this study aims to find a new therapy option. This Phase 2, randomized, double-blind, placebo-controlled pilot trial will assess the safety, tolerability, and effectiveness of BMS-986368 for this condition. Participants will be randomly assigned to receive either oral BMS-986368 or a placebo. The drug dosage will escalate from 1 mg once daily to 3 mg and then 6 mg once daily during the 8-week double-blind treatment period. Those who finish this period may join an optional 8-week extension where all receive active treatment while still blinded. The study also includes a screening phase lasting up to 4 weeks and a 4-week safety follow-up, totaling about 24 weeks. Throughout the study, participants will undergo assessments including the Tardieu Scale and Upper Limb Fugl-Meyer Assessment to measure spasticity and motor function. Additional evaluations will track symptoms, adverse events, and drug levels. Participants will be monitored for safety and tolerability during treatment and follow-up. The research aims to see if BMS-986368 improves muscle spasticity and upper limb function compared to placebo in adults with post-stroke spasticity.

CONDITIONS

Brief Title

A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)

Research Team

K

Kareema Murray

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here